Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-13

Clinical Trial Update: Treatment of Negative Symptoms of Schizophrenia With Transcranial Magnetic Stimulation (TMS) [Phase 2]

View source ↗

Summary

Phase 2 trial update for transcranial magnetic stimulation for negative symptoms in schizophrenia and schizoaffective disorder. The study was terminated and res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transcranial Magnetic Stimulation (TMS)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 2 | Status: TERMINATED | Results posted: 2017-01-13